Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00952627 · ClinicalTrials.gov registry record · Phase 2
Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects
A Phase 2 study, sponsored by University of Arizona.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00952627 is a Phase 2 study that was terminated before completion, run by University of Arizona. The registered enrollment target is 9 participants.
The verdict
NCT00952627, a Phase 2 study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Pycnogenol, a natural pine bark extract, is effective in modifying the age-dependent process of cardiac fibrosis and diastolic function in aged hypertensive subjects.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Pycnogenol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00952627
The ClinicalTrials.gov registry entry for NCT00952627 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00952627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00952627 about?
NCT00952627 is a clinical study titled "Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects". The purpose of this study is to determine whether Pycnogenol, a natural pine bark extract, is effective in modifying the age-dependent process of cardiac fibrosis and diastolic function in aged hypertensive subjects.
What is the current status of trial NCT00952627?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2009-07. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00952627?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Pycnogenol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00952627?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.